Status:
COMPLETED
Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip
Lead Sponsor:
Pfizer
Conditions:
Osteoarthritis, Hip
Eligibility:
All Genders
45+ years
Phase:
PHASE4
Brief Summary
To determine if celecoxib 200 mg once daily is as effective as diclofenac 50 mg three times daily in the treatment of pain symptoms associated with osteoarthritis of the hip
Eligibility Criteria
Inclusion
- Diagnosed with osteoarthritis of hip and requiring joint replacement
- Eligible for chronic therapy with an NSAID
Exclusion
- Hip surgery anticipated within 8 calendar weeks after first visit
- Active gastrointestinal disease or recent diagnosis of gastrointestinal ulceration (within 60 days of first visit)
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
End Date :
February 1 2005
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00174317
Start Date
August 1 2003
End Date
February 1 2005
Last Update
December 5 2006
Active Locations (44)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Aston Clinton, Bucks, United Kingdom, GP22 5LB
2
Pfizer Investigational Site
Ely, Cambs, United Kingdom, CB7 5JD
3
Pfizer Investigational Site
St Austell, Cornwall, United Kingdom, PL26 7DL
4
Pfizer Investigational Site
Lancaster, England, United Kingdom, LA1 2LG